Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01515540 · ClinicalTrials.gov registry record · Phase 4

Brain Imaging of Lidoderm for Chronic Back Pain

A Phase 4 study of Low Back Pain, sponsored by Northwestern University.

Completed
Registry status
Phase 4
Development phase
38
Enrollment target
1
Study location

NCT01515540 is a Phase 4 study of Low Back Pain that has completed, run by Northwestern University. The registered enrollment target is 38 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01515540, a Phase 4 study of Low Back Pain, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
Phase 4
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

The investigators tested whether pain decrease can be observed centrally with non-invasive brain imaging in CBP subjects receiving Lidoderm. The investigators first tested effects of 5% Lidoderm patched in an open labelled trial. Next the investigators compared the effects of Lidocaine versus Placebo patches. Three time points were evaluated: baseline (before treatment) and 6 hours and 2 weeks after treatment. The latter trial was a 2 arm, double blind, placebo controlled trial, where participants either received Lidoderm or placebo patches, without cross over.

Conditions Studied

Interventions

  • DRUG placebo
  • DRUG lidocaine

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2004-01
Est. Completion 2010-06
Phase Phase 4

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT01515540

The ClinicalTrials.gov registry entry for NCT01515540 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (92% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT01515540 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01515540 about?

NCT01515540 is a clinical study titled "Brain Imaging of Lidoderm for Chronic Back Pain". The investigators tested whether pain decrease can be observed centrally with non-invasive brain imaging in CBP subjects receiving Lidoderm. The investigators first tested effects of 5% Lidoderm patched in an open labelled trial. Next the investigators compared the effects of Lidocaine versus Placeb...

What is the current status of trial NCT01515540?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2004-01. Estimated completion is 2010-06.

What conditions does trial NCT01515540 study?

This clinical trial studies the following conditions: Low Back Pain.

What interventions are being tested in trial NCT01515540?

The interventions under investigation include: placebo (DRUG), lidocaine (DRUG).

Who is sponsoring clinical trial NCT01515540?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01515540 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.